IO Biotech Investor Relations Material
Latest events
Status Update
IO Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IO Biotech Inc
Access all reports
IO Biotech Inc. is a biotechnology company focused on developing immunotherapies for cancer. The company specializes in therapeutic cancer vaccines designed to stimulate the immune system to target and eliminate tumor cells. Its pipeline includes investigational treatments for various cancers, advancing through clinical trials and regulatory evaluations. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the NASDAQ.
Key slides for IO Biotech Inc
Corporate Presentation
IO Biotech Inc
Corporate Presentation
IO Biotech Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
IOBT
Country
🇺🇸 United States